Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process

Stock Information for Aclarion Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Aclarion Inc.

Aclarion Announces Addition of University of Arizona College of Medicine - Phoenix as CLARITY Trial Site
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan's Growing Role in Real-World Clinical Practice
Aclarion Announces Texas Spine Care Center as New CLARITY Site
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform
Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.